An international cooperative clinical study is divided into two applications: registration and exploratory. Does it need to apply for backup and filing separately for the outbound data information? | BradyKnows

Subscribe

Information backup and filing shall be conducted separately.

Suggested Reading

Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
What factors may affect biocompatibility risk when using biological test data from similar devices for…
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
Do all medical devices require chemical characterization?
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
How is the endotoxin limit for wound dressing products determined?

Previous: If the project data is submitted to other national administrative departments in stages, is it necessary to apply information back up and filing?

Next: Is it necessary to do information back up and filing by using the published data of human genetic resources?